Loading...
XHKG8225
Market cap25mUSD
Dec 23, Last price  
0.20HKD
1D
3.70%
1Q
63.33%
Jan 2017
-1.51%
Name

China Health Group Inc

Chart & Performance

D1W1MN
XHKG:8225 chart
P/E
—
P/S
8.55
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
0.05%
Rev. gr., 5y
-18.51%
Revenues
21m
+63.67%
36,157,00042,157,00057,052,00038,729,00039,186,00047,308,00037,687,00018,099,00028,688,00014,931,0005,956,00020,497,00020,241,00058,491,00059,606,00063,216,00083,063,00083,601,00013,090,00021,425,000
Net income
-58m
L+266.18%
10,767,0005,644,00015,563,0001,597,000-16,354,0006,276,000-56,928,000-153,796,0003,118,000-31,028,00044,117,000-3,353,0002,127,00030,454,00023,164,00027,792,00060,650,00036,325,000-15,843,000-58,014,000
CFO
1m
P
-17,829,000-734,000-1,836,000-22,623,000-30,653,0006,231,000-714,0006,716,000-6,617,000-1,779,00011,0003,390,000-6,893,00014,394,0002,858,000-485,00019,114,000-10,277,000-5,156,0001,121,000
Dividend
Apr 07, 20040.005 HKD/sh

Profile

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
URL
http://www.chgi.net
IPO date
Jul 10, 2003
Employees
40
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
21,425
63.67%
13,090
-84.34%
83,601
0.65%
Cost of revenue
78,756
21,320
34,177
Unusual Expense (Income)
NOPBT
(57,331)
(8,230)
49,424
NOPBT Margin
59.12%
Operating Taxes
17
6,196
Tax Rate
12.54%
NOPAT
(57,331)
(8,247)
43,228
Net income
(58,014)
266.18%
(15,843)
-143.61%
36,325
-40.11%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
5,784
Net debt
(7,303)
(12,070)
(17,024)
Cash flow
Cash from operating activities
1,121
(5,156)
(10,277)
CAPEX
(6,004)
Cash from investing activities
(1,041)
(2,148)
6,963
Cash from financing activities
(1,515)
FCF
(29,089)
(3,297)
287
Balance
Cash
7,303
12,070
17,024
Long term investments
1
Excess cash
6,232
11,416
12,844
Stockholders' equity
34,941
103,603
117,292
Invested Capital
77,951
105,472
116,488
ROIC
46.48%
ROCE
38.21%
EV
Common stock shares outstanding
995,352
995,352
995,352
Price
0.14
 
0.39
-8.33%
Market cap
137,359
 
383,211
-8.49%
EV
129,420
366,187
EBITDA
(57,097)
(8,079)
49,625
EV/EBITDA
7.38
Interest
17
15
Interest/NOPBT
0.03%